These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38104151)

  • 1. Targeting ST8SIA6-AS1 counteracts KRAS
    Wang Y; Yao M; Li C; Yang K; Qin X; Xu L; Shi S; Yu C; Meng X; Xie C
    Exp Hematol Oncol; 2023 Dec; 12(1):105. PubMed ID: 38104151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting PI3Kα overcomes resistance to KRas
    Qi WL; Li HY; Wang Y; Xu L; Deng JT; Zhang X; Wang YX; Meng LH
    Acta Pharmacol Sin; 2023 May; 44(5):1083-1094. PubMed ID: 36411339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells.
    Luo ML; Li J; Shen L; Chu J; Guo Q; Liang G; Wu W; Chen J; Chen R; Song E
    J Natl Cancer Inst; 2020 Apr; 112(4):356-368. PubMed ID: 31286138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis.
    He J; Yan H; Wei S; Chen G
    Onco Targets Ther; 2021; 14():3209-3223. PubMed ID: 34040387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis.
    Fei Q; Song F; Jiang X; Hong H; Xu X; Jin Z; Zhu X; Dai B; Yang J; Sui C; Xu M
    Cancer Cell Int; 2020; 20():232. PubMed ID: 32536820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer.
    Adachi Y; Ito K; Hayashi Y; Kimura R; Tan TZ; Yamaguchi R; Ebi H
    Clin Cancer Res; 2020 Nov; 26(22):5962-5973. PubMed ID: 32900796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
    Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ST8SIA6-AS1 promotes colorectal cancer cell proliferation, migration and invasion by regulating the miR-5195/PCBP2 axis.
    Huang CM; Cao GY; Yang CX; Chen Y; Liu GD; Xu BW; Zhang X
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4203-4211. PubMed ID: 32373956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.
    Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
    Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP2 Contributes to Resistance of KRAS p.G12C-Driven Lung Cancer Cells to MRTX849 by Regulating β-catenin/c-MYC Axis.
    Li W; Wu Y; Dai L; Wang W; Zhao L
    Ann Clin Lab Sci; 2023 Jul; 53(4):630-640. PubMed ID: 37625842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to KRAS
    Blaquier JB; Cardona AF; Recondo G
    Front Oncol; 2021; 11():787585. PubMed ID: 35004309
    [No Abstract]   [Full Text] [Related]  

  • 14. ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis.
    Kuai J; Zheng L; Yi X; Liu Z; Qiu B; Lu Z; Jiang Y
    Dig Liver Dis; 2021 Sep; 53(9):1192-1200. PubMed ID: 33722502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Breakthrough Brought about by Targeting KRAS
    Ning W; Yang Z; Kocher GJ; Dorn P; Peng RW
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
    Li Y; Jiang A
    Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-X
    Khan S; Wiegand J; Zhang P; Hu W; Thummuri D; Budamagunta V; Hua N; Jin L; Allegra CJ; Kopetz SE; Zajac-Kaye M; Kaye FJ; Zheng G; Zhou D
    J Hematol Oncol; 2022 Mar; 15(1):23. PubMed ID: 35260176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS Inhibitor Resistance in
    Suzuki S; Yonesaka K; Teramura T; Takehara T; Kato R; Sakai H; Haratani K; Tanizaki J; Kawakami H; Hayashi H; Sakai K; Nishio K; Nakagawa K
    Clin Cancer Res; 2021 Oct; 27(20):5697-5707. PubMed ID: 34365406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis.
    Mou Y; Ding X
    Anticancer Drugs; 2022 Sep; 33(8):741-751. PubMed ID: 35946523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
    Chen Z; Huang J; Feng Y; Li Z; Jiang Y
    J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.